Literature DB >> 24149480

The impact of short term supervised and home-based walking programmes on heart rate variability in patients with peripheral arterial disease.

Gavin R H Sandercock1, Lynette D Hodges, Saroj K Das, David A Brodie.   

Abstract

The aims of the study were to determine whether heart rate variability (HRV) measured at rest and during exercise could be altered by an exercise training programme designed to increase walking performance in patients with peripheral arterial disease. Forty-four volunteers were randomised into 12 weeks of either: supervised walking training twice weekly for 30 min at 75% VO2peak (SU), home-based walking training sessions: twice weekly, 30 min per week (HB) or no exercise (CT). HRV measures were calculated from a 5-min resting ECG. Each patient then underwent maximal, graded exercise treadmill testing. All measures were repeated after 12 weeks. The SU group showed significantly (p < 0.001) increased maximal walking time (MWT) but no change in VO2peak. There were no statistically significant changes in any of the measures of HRV in any group. Effect sizes for change in HRV measures were all very small and in some cases negative. Improved walking performance was not accompanied by central cardiorespiratory or neuroregulatory adaptations in the present study. The lack of any change in HRV was possibly due to either the low intensity or discontinuous nature of exercise undertaken. Key pointsIt is known that exercise can positively influence heart rate variability in some cardiac patients.It is known that exercise can increase walking performance in peripheral vascular disease patients.Exercise training improved walking performance in peripheral vascular disease patients but HRV was unaltered.This may be due to low overall physiological demands on the cardiovascular system or the intermittent nature of the exercise.

Entities:  

Keywords:  Exercise; autonomic nervous system; ischemia

Year:  2007        PMID: 24149480      PMCID: PMC3794487     

Source DB:  PubMed          Journal:  J Sports Sci Med        ISSN: 1303-2968            Impact factor:   2.988


  31 in total

1.  Exercise conditioning and heart rate variability: evidence of a threshold effect.

Authors:  Y Pardo; C N Merz; I Velasquez; M Paul-Labrador; A Agarwala; C T Peter
Journal:  Clin Cardiol       Date:  2000-08       Impact factor: 2.882

Review 2.  Functional outcomes and quality of life in peripheral arterial disease: current status.

Authors:  Mark R Nehler; Mary M McDermott; Diane Treat-Jacobson; Ian Chetter; Judith G Regensteiner
Journal:  Vasc Med       Date:  2003-05       Impact factor: 3.239

3.  Changes in short-term measures of heart rate variability after eight weeks of cardiac rehabilitation.

Authors:  Gavin R H Sandercock; Richard Grocott-Mason; David A Brodie
Journal:  Clin Auton Res       Date:  2007-02-06       Impact factor: 4.435

4.  World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.

Authors: 
Journal:  Cardiovasc Res       Date:  1997-07       Impact factor: 10.787

5.  Aerobic group training improves exercise capacity and heart rate variability in elderly patients with a recent coronary event. A randomized controlled study.

Authors:  A Stâhle; R Nordlander; L Bergfeldt
Journal:  Eur Heart J       Date:  1999-11       Impact factor: 29.983

6.  Comparison of three recumbent positions on vagal and sympathetic modulation using spectral heart rate variability in patients with coronary artery disease.

Authors:  C D Kuo; G Y Chen
Journal:  Am J Cardiol       Date:  1998-02-15       Impact factor: 2.778

7.  Intensive home-based exercise training in cardiac rehabilitation increases exercise capacity and heart rate variability.

Authors:  H Tygesen; C Wettervik; B Wennerblom
Journal:  Int J Cardiol       Date:  2001-07       Impact factor: 4.164

8.  Postural response of low-frequency component of heart rate variability is an increased risk for mortality in patients with coronary artery disease.

Authors:  J Hayano; S Mukai; H Fukuta; S Sakata; N Ohte; G Kimura
Journal:  Chest       Date:  2001-12       Impact factor: 9.410

9.  Effect of aging on gender differences in neural control of heart rate.

Authors:  T B Kuo; T Lin; C C Yang; C L Li; C F Chen; P Chou
Journal:  Am J Physiol       Date:  1999-12

10.  Relationship between temporal-spatial gait parameters, gait kinematics, walking performance, exercise capacity, and physical activity level in peripheral arterial disease.

Authors:  Robert G Crowther; Warwick L Spinks; Anthony S Leicht; Frank Quigley; Jonathan Golledge
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

View more
  5 in total

Review 1.  Peripheral arterial disease: Scoping review of patient-centred outcomes.

Authors:  Laura Bolton
Journal:  Int Wound J       Date:  2019-10-09       Impact factor: 3.315

Review 2.  Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication.

Authors:  David Hageman; Hugo Jp Fokkenrood; Lindy Nm Gommans; Marijn Ml van den Houten; Joep Aw Teijink
Journal:  Cochrane Database Syst Rev       Date:  2018-04-06

3.  Safety of home-based exercise for people with intermittent claudication: A systematic review.

Authors:  Alexander Waddell; Sally Seed; David R Broom; Gordon McGregor; Stefan T Birkett; Amy E Harwood
Journal:  Vasc Med       Date:  2021-12-20       Impact factor: 3.239

4.  Intensity-dependent effects of exercise therapy on walking performance and aerobic fitness in symptomatic patients with lower-extremity peripheral artery disease: A systematic review and meta-analysis.

Authors:  Mattia Fassora; Luca Calanca; Cécile Jaques; Lucia Mazzolai; Bengt Kayser; Stefano Lanzi
Journal:  Vasc Med       Date:  2021-09-28       Impact factor: 3.239

5.  Association between attending exercise-based cardiac rehabilitation and cardiovascular risk factors at one-year post myocardial infarction.

Authors:  Ingela Sjölin; Maria Bäck; Lennart Nilsson; Alexandru Schiopu; Margret Leosdottir
Journal:  PLoS One       Date:  2020-05-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.